Freezing nerves may beat standard pain shots after lung surgery
NCT ID NCT07099469
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small pilot study with 6 people compares two ways to manage pain after minimally invasive lung cancer surgery. One method uses a standard numbing injection (ropivacaine), while the other uses cryotherapy to freeze the nerves for longer-lasting pain relief (1-3 months). The goal is to see if cryotherapy reduces the need for pain medication and improves recovery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 6 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2025
- Expected to finish
-
Nov 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients referred for anatomical lung resection (lobectomy or segmentectomy) with the intention of performing it by robotic-assisted thoracoscopic surgery (RATS) are eligible for the trial.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Adult patients of 18 years or older who are able to give informed consent and fill out questionnaires in Dutch. Exclusion Criteria: * Patients who need an anatomic resection of the lung that's larger than one lung lobe, who have CPAM or infections. * Patients with chronic use (\>3 months) of strong opioids because of co-morbidities -for example, the use of tramadol is allowed. * If there's a high risk of conversion to a thoracotomy. This will be evaluated by the lung surgeon. * Patients who have had thoracic surgery in the past. * Patients with chronic kidney disease stage 4 or 5 (GFR \< 30 mL/min)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lung cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Antwerp
Edegem, Antwerp, 2560, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Surgeons could freeze lung tumors from miles away using 5G robots
- Can AI make lung cancer scans easier to read?
- Two-Drug combo targets Treatment-Resistant lung cancer
- Can an Anti-Fibrotic drug shield lungs from radiation after immunotherapy?
- App aims to catch a hidden radiotherapy side effect
- Which nerve block wins for lung surgery pain?